FIQRX
Price
$20.63
Change
-$0.13 (-0.63%)
Updated
Sep 3 closing price
Net Assets
895.5M
SBMBX
Price
$12.16
Change
-$0.20 (-1.62%)
Updated
Sep 3 closing price
Net Assets
1.01M
Interact to see
Advertisement

FIQRX vs SBMBX

Header iconFIQRX vs SBMBX Comparison
Open Charts FIQRX vs SBMBXBanner chart's image
Fidelity Advisor Global Commodity Stk Z
Price$20.63
Change-$0.13 (-0.63%)
VolumeN/A
Net Assets895.5M
Saratoga Energy & Basic Materials A
Price$12.16
Change-$0.20 (-1.62%)
VolumeN/A
Net Assets1.01M
FIQRX vs SBMBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FIQRX vs. SBMBX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIQRX is a Buy and SBMBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FIQRX has more cash in the bank: 895M vs. SBMBX (1.01M). FIQRX pays higher dividends than SBMBX: FIQRX (2.36) vs SBMBX (0.81). FIQRX was incepted earlier than SBMBX: FIQRX (7 years) vs SBMBX (28 years). SBMBX (3.81) is less costly to investors than FIQRX (0.76). FIQRX (49.00) and SBMBX (47.00) have comparable annual turnover. FIQRX has a lower initial minimum investment than SBMBX: FIQRX (0) vs SBMBX (250). FIQRX annual gain was more profitable for investors over the last year : 14.81 vs. SBMBX (0.24). FIQRX return over 5 years is better than : 105.63 vs. SBMBX (76.53).
FIQRXSBMBXFIQRX / SBMBX
Total Expense Ratio0.763.8120%
Annual Report Gross Expense Ratio0.763.8120%
Fund Existence7 years28 years-
Gain YTD15.9787.013228%
Front LoadN/A6%-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets895M1.01M88,264%
Annual Yield % from dividends2.360.81293%
Returns for 1 year14.810.246,081%
Returns for 3 years18.3115.58118%
Returns for 5 years105.6376.53138%
Returns for 10 yearsN/A25.93-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.510.51
+10.20%
Vir Biotechnology
MRCC7.610.11
+1.40%
Monroe Capital Corp
VTR67.45-0.47
-0.69%
Ventas
ITGR105.84-1.13
-1.06%
Integer Holdings Corp
CMMB3.02-0.08
-2.58%
Chemomab Therapeutics Ltd